Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Patrick Omara Net Worth & Insider Trades

Patrick Omara - SVP, Cymabay Therapeutics, Inc

As of January 26, 2018

What is Patrick Omara's Net Worth?

The current estimated net worth of Cymabay Therapeutics, Inc's SVP, Patrick Omara, is estimated to be about $40.68K . Patrick Omara owns about 5,022 units of Cymabay Therapeutics, Inc common stock. In the last 2 years at Cymabay Therapeutics, Inc, Patrick Omara has sold an estimated value of $0 worth.

What is Patrick Omara's Past Insider Trading?

Patrick Omara's largest purchase order was 5,000 units , worth over $8.2K on April 19, 2016. In total, Patrick Omara has made about 6 transactions over 2 years of their time at Cymabay Therapeutics, Inc. Patrick Omara usually trades in January, with the busiest year in 2017.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Patrick OMara

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Patrick Omara's' Mailing Address?

  • Mailing address is C/o Cymabay Therapeutics, Inc. 7999 Gateway Blvd., Suite 130 Newark CA 94560 CA

What are Cymabay Therapeutics, Inc's Past Insider Trades?

Cymabay Therapeutics, Inc's most recent insider trade came on November 17, 2023 by Charles McWherter who sold 11,342 units worth $207.29K . In the last 8 years, insiders at Cymabay Therapeutics, Inc have sold an estimated value of $24.88M and bought an estimated value of $9.35M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Kurt von Emster, Director,  Sujal Shah, Chief Executive Officer,  and Charles McWherter, President R&D .

CymaBay Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...